Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus
Open Access
- 25 September 2013
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-6
Abstract
Systemic lupus erythematosus (SLE) patients frequently have high circulating tumor necrosis factor alpha (TNF-α) levels. We explored circulating TNF-αlevels in SLE families to determine whether high levels of TNF-αwere clustered in a heritable pattern. We measured TNF-αin 242 SLE patients, 361 unaffected family members, 23 unaffected spouses of SLE patients, and 62 unrelated healthy controls. Familial correlations and relative recurrence risk rates for the high TNF-αtrait were assessed. SLE-affected individuals had the highest TNF-αlevels, and TNF-αwas significantly higher in unaffected first degree relatives than healthy unrelated subjects. No Mendelian patterns were observed, but 28.4% of unaffected first degree relatives of SLE patients had high TNF-αlevels, resulting in a first degree relative recurrence risk of 4.48. Interestingly, the median TNF-αvalue in spouses was similar to that of the first degree relatives. Concordance of the TNF-αtrait (high versus low) in SLE patients and their spouses was strikingly high at 78.2%. These data support a role for TNF-αin SLE pathogenesis, and TNF-αlevels may relate with heritable factors. The high degree of concordance in SLE patients and their spouses suggests that environmental factors may also play a role in the observed familial aggregation.
Keywords
Funding Information
- U.S. Department of Veterans Affairs (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- U.S. Department of War (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- National Institutes of Health (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
- Lupus Research Institute (PR094002, N01AR62277, R37AI024717, R01AR042460, P01AI083194, P20RR020143, P01AR049084, U01HG006828, P30AR053483, P30GM103510, U01AI101934, U19AI082714, R01AR043274, R01AR060861, K08AI083790, L30AI071651, UL1RR024999)
This publication has 41 references indexed in Scilit:
- Serum type I interferon activity is dependent on maternal diagnosis in anti‐SSA/Ro–positive mothers of children with neonatal lupusArthritis & Rheumatism, 2008
- High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosusGenes & Immunity, 2007
- Unraveling the genetics of systemic lupus erythematosusSpringer Seminars in Immunopathology, 2006
- Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti–RNA binding protein autoantibodiesArthritis & Rheumatism, 2006
- Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis CClinical Rheumatology, 2004
- Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic interventionLupus, 2004
- Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase familiesArthritis & Rheumatism, 1999
- An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.Journal of Clinical Investigation, 1997
- TUMOUR NECROSIS FACTOR ALPHA AND ITS SOLUBLE RECEPTORS PARALLEL CLINICAL DISEASE AND AUTOIMMUNE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1995
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988